Back to MW MARSHALL WACE, LLP

RIGLRIGL
20 quarters

Position history for MWMARSHALL WACE, LLP's holdings in RIGEL PHARMACEUTICALS INC

MARSHALL WACE, LLP holds 598,378 shares of RIGL (RIGEL PHARMACEUTICALS INC), worth $16.2M as of 2026-Q1. The position was decreased (-2.5% shares). RIGL represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$16.2M

Current Shares

598,378

Total Value Change

+$15.4M

Total Shares Change

+262,209

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
598,378
-2.5%
$16.2M0.0%$33.02
0
2025-Q4
Increased
613,600
+2.0%
$26.3M0.0%$42.83
29
2025-Q3
Increased
601,333
+63.0%
$17M0.0%$28.75
41
2025-Q2
Increased
368,950
+74.2%
$6.9M0.0%$19.48
41
2025-Q1
New
211,748
-
$3.8M0.0%$17.88
37
2024-Q2
Exited
0
-100.0%
$00.0%$8.22
0
2024-Q1
New
438,562
-
$649,0710.0%$14.80
34
2023-Q4
Exited
0
-100.0%
$00.0%$14.50
0
2023-Q3
New
36,017
-
$38,8980.0%$10.80
28
2023-Q2
Exited
0
-100.0%
$00.0%$13.40
0
2023-Q1
New
172,731
-
$228,0050.0%$13.40
32
2021-Q4
Exited
0
-100.0%
$00.0%$26.80
0
2021-Q3
New
69,222
-
$251,0000.0%$36.30
32
2020-Q3
Exited
0
-100.0%
$00.0%$22.90
0
2020-Q2
New
27,304
-
$50,0000.0%$18.00
28
2019-Q4
Exited
0
-100.0%
$00.0%$21.00
0
2019-Q3
Decreased
709,026
-43.1%
$1.3M0.0%$18.30
0
2019-Q2
Increased
1.2M
+8.7%
$3.3M0.0%$26.10
29
2019-Q1
Increased
1.1M
+241.0%
$2.9M0.0%$25.70
42
2018-Q4
New
336,169
-
$773,0000.0%$22.40
34

Other major holders of RIGL: BlackRock, Inc., STATE STREET CORP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used